Virtual Case Studies™ in Alzheimer Disease: Applying Neuroimaging Strategies to Inform Diagnosis and Treatment

Released On
April 30, 2021

Expires On
April 30, 2022

Media Type

Completion Time
75 minutes

Neurology, Psychiatry

Aging, Alzheimer's, Dementia, Geriatric Medicine

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.


This activity is supported by an educational grant from Biogen .

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This program is intended for neurologists, radiologists, neuroradiologists, and other healthcare professionals involved in the diagnosis and management of patients with Alzheimer disease, including primary care physicians, physician assistants, nurse practitioners, and nurses.

Program Overview

Virtual Case Studies™ is an engaging and interactive case-based program that provides concise and easy-to-digest education on the use of neuroimaging in the diagnosis and management of patients with Alzheimer disease. The engaging multimedia format of this program includes two case studies featuring video clips of fictional patients and physicians navigating clinical decision points, interactive questions followed by explanations of the optimal response, and concludes with a discussion of diagnosis and treatment-related strategies by a panel of distinguished experts.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify the pathological hallmarks of Alzheimer disease
  • Apply guidelines-based recommendations on the use of neuroimaging techniques to differentiate Alzheimer disease from other similar conditions
  • Discuss the importance of early diagnosis in Alzheimer disease and recent advances in neuroimaging and the role it plays in facilitating early and accurate diagnosis
  • Analyze emerging trends in neuroimaging assessment and its potential role in diagnosis, monitoring, and management of Alzheimer disease with respect to future treatment paradigms
  • Evaluate the impact of emerging advances and techniques in neuroimaging on diagnosis and management of patients with Alzheimer disease



Liana Apostolova, MD, MSc, FAAN

Indiana University Distinguished Professor
Barbara and Peer Baekgaard Professor in Alzheimer’s Disease Research
Department of Neurology
Indiana University School of Medicine
Indianapolis, IN


Matthew R. Ayers, DO

Department of Psychiatry
Veteran Health Indiana
Indianapolis, IN


Gad A. Marshall, MD

Director of Clinical Trials
Center for Alzheimer Research and Treatment
Brigham and Women’s Hospital
Massachusetts General Hospital
Associate Professor of Neurology
Harvard Medical School
Boston, MA


Stephen Salloway, MD, MS

Director, Memory and Aging Program
Chief of Neurology, Butler Hospital
Professor of Neurology and Martin M. Zucker Professor of Psychiatry and Human Behavior,
Warren Alpert Medical School, Brown University
Providence, RI

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Liana Apostolova, MD, MSc, FAAN

  • Grant Research Support: NIA UOl AG057195. NIA ROl AG057739. NIA P30AG010133 Alzheimer’s Association Leads Genetics 19-639372, Roche Diagnostics RD005665
  • Consultant: Biogen, Two Labs, IQVIA
  • Stock/Shareholder: Semiring Inc.

Matthew R. Ayers, DO, has no relevant financial relationships with ineligible companies.

Gad A. Marshall, MD

  • Grant Research Support: Eisai, Inc., Eli Lilly and Company, Genentech, Novartis
  • Consultant: Grifols

Stephen Salloway, MD, MS

  • Grant Research Support: Roche, Lilly
  • Consultant: Roche, Biogen, Lilly, GemVax, Amgen, Avid

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Instructions for Participation and Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.
You may immediately download your certificate.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.